Medical and Social Evaluation of the Impact of Remote Health Monitoring in Patients with Circulatory System Diseases at the Primary Care Stage

Riabkov S.O.

Main
Publications
Medical and Social Evaluation of the Impact of Remote Health Monitoring in Patients with Circulatory System Diseases at the Primary Care Stage

January 8, 2025

167

Digital medicine

Riabkov S.O.

УДК: 614.2:616.1-07-082-039.57:004.77

DOI: 10.32471/umj.1680-3051.261967

Keywords :

diseases of the circulatory system,

primary health care,

quality of life remains,

remote monitoring,

telemedicine

Specialities :

Digital medicine

Resume

Remote health monitoring is an innovative approach to monitoring patients with circulatory system diseases in primary care. The study’s main objective is to assess the effectiveness of telemedicine technologies for monitoring patients with circulatory system diseases and determine their impact on the quality of healthcare services. The study shows significant benefits of implementing remote monitoring, which include improved control of key health indicators (blood pressure, heart rate, glucose levels, etc.), reduced number of unscheduled hospitalisations due to timely detection of deviations in patients’ condition, and increased adherence to treatment due to the possibility of constant contact with medical staff. In addition, remote monitoring allows for timely detection of complications, optimisation of healthcare costs and improvement of the overall effectiveness of treatment. The study focuses on the psychological comfort of patients who receive personalised support without frequent visits to medical institutions, which is important for people with chronic diseases. The results of the study confirm that the introduction of remote monitoring contributes to the improvement of clinical indicators and quality of life of patients with circulatory system diseases, and the expansion of the use of telemedicine technologies in primary care practice will improve the level of medical services reduce the burden on the healthcare system and efficiently use medical resources.

References

1. Timmis A., Vardas P., Townsend N. et al. (2022) European Society of Cardiology: Cardiovascular disease statistics 2021. Eur. Heart J., 43(8): 716–799.
2. Benjamin E.J., Muntner P., Alonso A. et al. (2021) Heart disease and stroke statistics — 2021 update: A report from the American Heart Association. Circulation, 143(8): 254–743. doi.org/10.1161/CIR.0000000000000950.
3. World Health Organization (2024) The top 10 causes of death. http://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
4. Roth G.A., Mensah G.A., Johnson C.O. et al. (2020) Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 study. J. Am. College Cardiol., 76(25): 2982–3021.
5. Khan M.A., Hashim M.J., Mustafa H. et al. (2020) Global epidemiology of ischemic heart disease: Results from the global burden of disease study. Cureus, 12(7): e9349.
6. Elmusharaf K., Grafton D., Jung J.S. et al. (2022) The case for investing in the prevention and control of non-communicable diseases in the six countries of the Gulf Cooperation Council: An economic evaluation. BMJ Global Health, 7(6): e008670.
7. Сіренко Ю.М. (2022) Стан проблеми серцево-судинної захворюваності та смертності в Україні. Ліки України, 2(258): 11–14.
8. Гідзинська І.М., Мороз Г.З., Грива А.В. та ін. (2020) Assessment of achieving target blood pressure level in patients with coronary heart disease and hypertension. Клінічна та профілактична медицина, 4: 26–32.
9. Piepoli M.F., Abreu A., Albus C. et al. (2020) Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology. Eur. J. Prevent. Cardiol., 27(2): 181–205.
10. World Health Organization (2022) Action plan for the prevention and control of noncommunicable diseases in South-East Asia, 2013–2020: extended to 2030 (No. SEA-NCD-101). World Health Organization. Regional Office for South-East Asia.
11. World Health Organization (2023) Assessing national capacity for the prevention and control of noncommunicable diseases: Report of the 2021 global survey.
12. World Health Organization (2020) Hearts: Technical package for cardiovascular disease management in primary health care: Risk-based CVD management.
13. Willis V.C., Thomas Craig K.J., Jabbarpour Y. et al. (2022) Digital health interventions to enhance prevention in primary care: Scoping review. JMIR Med. Inf., 10(1): e33518.
14. Esteve-Matalí L., Vargas I., Sánchez E. et al. (2020) Do primary and secondary care doctors have a different experience and perception of cross-level clinical coordination? Results of a cross-sectional study in the Catalan National Health System (Spain). BMC Family Practice, 21: 1–14. doi.org/10.1186/s12875-020-01207-9.
15. Arasaratnam D., Via M.A., Mechanick J.I. (2023) Tertiary prevention using lifestyle medicine for cardiometabolic-based chronic disease. In Integrating lifestyle medicine for prediabetes, type 2 diabetes, and cardiometabolic disease (pp. 151–186).
16. Taylor R.S., Walker S., Smart N.A. et al. (2019) Impact of exercise rehabilitation on exercise capacity and quality-of-life in heart failure: Individual participant meta-analysis. J. Am. College Cardiol., 73(12): 1430–1443.
17. Luengo-Fernandez R., Walli-Attaei M., Gray A. et al. (2023) Economic burden of cardiovascular diseases in the European Union: A population-based cost study. Eur. Heart J., 44(45): 4752–4767.
18. Laranjo L., Lanas F., Sun M.C. et al. (2024) World Heart Federation roadmap for secondary prevention of cardiovascular disease: 2023 update. Global Heart, 19(1).
19. Blaya J.A., Fraser H.S., Holt B. (2010) E-health technologies show promise in developing countries. Health Affairs, 29(2): 244–251.
20. Omboni S., Padwal R.S., Alessa T. et al. (2022) The worldwide impact of telemedicine during COVID-19: Current evidence and recommendations for the future. Connected Health, 1: 7. doi.org/10.20517/ch.2021.03.
21. Milewski K., Balsam P., Kachel M. et al. (2023) Actual status and future directions of cardiac telerehabilitation. Cardiology J., 30(1): 12–23.
22. Asadi H., Toni E., Ayatollahi H. (2024) Application of telemedicine technology for cardiovascular diseases management during the COVID-19 pandemic: A scoping review. Frontiers in Cardiovascular Medicine, 11: 1397566.
23. Malanchini G.G., Leidi C., Ferrari P. et al. (2021) Challenges in the remote monitoring of cardiac implantable electronic devices in 2021. Kardiologia Polska (Polish Heart Journal, 79(4): 380–385. doi.org/10.33963/KP.15899.
24. Ferrick A.M., Raj S.R., Deneke T. et al. (2023) 2023 HRS/EHRA/APHRS/LAHRS expert consensus statement on practical management of the remote device clinic. Europace, 25(5): euad123. doi.org/10.1093/europace/euad123.
25. Santos M.A., Munoz R., Olivares R. et al. (2020) Online heart monitoring systems on the internet of health things environments: A survey, a reference model and an outlook. Information Fusion, 53: 222–239.
26. Chen S., Qi J., Fan S. et al. (2021) Flexible wearable sensors for cardiovascular health monitoring. Adv. Healthcare Materials, 10(17): 2100116.
27. Alshamrani M. (2022) IoT and artificial intelligence implementations for remote healthcare monitoring systems: A survey. J. King Saud Univ.-Comp. Inf. Sci., 34(8): 4687–4701.
28. Batalik L., Dosbaba F., Hartman M. et al. (2020) Benefits and effectiveness of using a wrist heart rate monitor as a telerehabilitation device in cardiac patients: A randomized controlled trial. Medicine, 99(11): e19556.
29. Bekfani T., Fudim M., Cleland J.G. et al. (2021) A current and future outlook on upcoming technologies in remote monitoring of patients with heart failure. European Journal of Heart Failure, 23(1): 175–185. doi.org/10.1002/ejhf.2033.
30. Rakhimov T., Mukhamediev M. (2022) Implementation of digital technologies in the medicine of the future. Futurity Medicine, 1(2): 14–25.
31. Ilina-Stohniienko V., Malets M. (2022) Regarding the modernisation of medical care system for victims of armed conflicts (Ukrainian experience). Futurity Medicine, 1(3): 35–49. doi.org/10.57125/FEM.2022.06.30.02.
32. Krittanawong C., Rogers A.J., Johnson K.W. et al. (2021) Integration of novel monitoring devices with machine learning technology for scalable cardiovascular management. Nature Reviews Cardiology, 18(2): 75–91.
33. Kennel P.J., Rosenblum H., Axsom K.M. et al. (2022) Remote cardiac monitoring in patients with heart failure: A review. JAMA Cardiology, 7(5): 556–564.
34. Murugan K., Murugeswari S., Reddy J.P. et al. (2021) Smart medical telemetry acquisition system. In 2021 Second International Conference on Electronics and Sustainable Communication Systems (ICESC) (pp. 1289–1297).
35. Palozzi G., Schettini I., Chirico A. (2020) Enhancing the sustainable goal of access to healthcare: Findings from a literature review on telemedicine employment in rural areas. Sustainability, 12(8): 3318. doi.org/10.3390/su12083318.
36. Salsabilla A., Azzahra A.B., Syafitri R.I. et al. (2021) Cost-effectiveness of telemedicine in Asia: A scoping review. Journal of Multidisciplinary Healthcare, 14: 3587–3596. doi.org/10.2147/JMDH.S332579.
37. Ramos S., Barreras N., Salvatierra G. et al. (2023) Real-world evidence of using telemedicine to capture electronic PROM improves quality of life assessment, healthcare resources management, and overall survival in patients with lymphoma. HemaSphere, 7(S3): e3331772.
38. Adegh E.P., Okolo C.A., Ojeyinka O.T. (2024) A review of emerging trends in telemedicine: Healthcare delivery transformations. Int. J. Life Sci. Res. Arch., 6(1): 137–147. doi.org/10.53771/ijlsra.2024.6.1.0040.
39. Brands M.R., Gouw S.C., Beestrum M. et al. (2022) Patient-centered digital health records and their effects on health outcomes: Systematic review. J. Med. Int. Res., 24(12): e43086. doi.org/10.2196/43086.
40. Han X., Chen W., Gao Z. et al. (2021) Effectiveness of telemedicine for cardiovascular disease management: Systematic review and meta-analysis. Annals of Palliative Med., 10(12): 12831–12844. doi.org/10.21037/apm-21-3626.
41. Farabi H., Rezapour A., Jahangiri R. et al. (2020) Economic evaluation of the utilization of telemedicine for patients with cardiovascular disease: A systematic review. Heart Failure Rev., 25: 1063–1075. doi.org/10.1007/s10741-019-09864-4.
42. Richardson S., Lawrence K., Schoenthaler A.M., Mann D. (2022) A framework for digital health equity. NPJ Digital Medicine, 5(1): 119.
43. Bakshi S., Tandon U. (2022) Understanding barriers of telemedicine adoption: A study in North India. Systems Research and Behavioral Science, 39(1): 128–142.
44. Awad A., Trenfield S.J., Pollard T.D. et al. (2021) Connected healthcare: Improving patient care using digital health technologies. Advanced Drug Delivery Reviews, 178: 113958. doi.org/10.1016/j.addr.2021.113958.
45. Rasool S., Tariq A., Hayat Y. (2023) Maximizing efficiency in telemedicine: An IoT-based artificial intelligence optimization framework for health analysis. European Journal of Science, Innovation and Technology, 3(6): 48–61.
46. Nwosu N.T. (2024) Reducing operational costs in healthcare through advanced BI tools and data integration. World J. Adv. Res. Rev., 22(3): 1144–1156.
47. Guo C., Ashrafian H., Ghafur S. et al. (2020) Challenges for the evaluation of digital health solutions: A call for innovative evidence generation approaches. NPJ Digital Med., 3(1): 110.
48. Velez F.F., Colman S., Kauffman L. et al. (2021) Real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic. Exp. Rev. Pharmacoecon. Outcomes Res., 21(1): 69–76.
49. Levy M.L., Bacharier L.B., Bateman E. et al. (2023) Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update. NPJ Prim. Care Resp. Med., 33(1): 1–13.
50. Arnetz B.B., Goetz C.M., Arnetz J.E. et al. (2020) Enhancing healthcare efficiency to achieve the Quadruple Aim: An exploratory study. BMC Res. Notes, 13(1): 1–6.
51. Saigí-Rubió F., Borges do Nascimento I.J., Robles N. et al. (2022) The current status of telemedicine technology use across the World Health Organization European region: An overview of systematic reviews. J. Med. Int. Res., 24(10): e40877.
52. Farias F.A.C.D., Dagostini C.M., Bicca Y.D.A. et al. (2020) Remote patient monitoring: A systematic review. Telemedicine and e-Health, 26(5): 576–583.
53. Shimbo D., Artinian N.T., Basile J.N. et al. (2020) Self-measured blood pressure monitoring at home: A joint policy statement from the American Heart Association and American Medical Association. Circulation, 142(4): e42–e63.
54. Nittari G., Khuman R., Baldoni S. et al. (2020) Telemedicine practice: Review of the current ethical and legal challenges. Telemedicine and e-Health, 26(12): 1427–1437.
55. Theodos K., Sittig S. (2020) Health information privacy laws in the digital age: HIPAA doesn’t apply. Perspectives in Health Information Management, 18(Winter): 1l.
56. Ratta P., Kaur A., Sharma S. et al. (2021) Application of blockchain and internet of things in healthcare and medical sector: Applications, challenges, and future perspectives. J. Food Qual., 2021(1): 7608296.
57. Lokken T.G., Blegen R.N., Hoff M.D., Demaerschalk B.M. (2020) Overview for implementation of telemedicine services in a large integrated multispecialty health care system. Telemedicine and e-Health, 26(4): 382–387.
58. Abounassar E.M., El-Kafrawy P., Abd El-Latif A.A. (2022) Security and interoperability issues with internet of things (IoT) in healthcare industry: A survey. In Security and Privacy Preserving for IoT and 5G Networks: Techniques, Challenges, and New Directions (pp. 159–189). Springer.
59. Solimini R., Busardò F.P., Gibelli F. et al. (2021) Ethical and legal challenges of telemedicine in the era of the COVID-19 pandemic. Medicina, 57(12): 1314.
60. Van Kessel R., Hrzic R., O’Nuallain E. et al. (2022) Digital health paradox: International policy perspectives to address increased health inequalities for people living with disabilities. J. Med. Int. Res., 24(2): e33819.
61. Jamil F., Ahmad S., Iqbal N. et al. (2020) Towards a remote monitoring of patient vital signs based on IoT-based blockchain integrity management platforms in smart hospitals. Sensors, 20(8): 2195. doi.org/10.3390/s20082195.
62. Singla D.R., Lemberg-Pelly S., Lawson A. et al. (2020) Implementing psychological interventions through nonspecialist providers and telemedicine in high-income countries: Qualitative study from a multistakeholder perspective. JMIR Ment. Health, 7(8): e19271.
63. Marshal R., Gobinath K., Rao V.V. (2021) Proactive measures to mitigate cybersecurity challenges in IoT-based smart healthcare networks. In 2021 IEEE International IoT, Electronics and Mechatronics Conference (IEMTRONICS) (pp. 1–4). IEEE.
64. Prieto-Avalos G., Cruz-Ramos N.A., Alor-Hernandez G. et al. (2022) Wearable devices for physical monitoring of heart: A review. Biosensors, 12(5): 292.
65. Le Goff-Pronost M., Bongiovanni-Delarozière I. (2023) Economic evaluation of remote patient monitoring and organizational analysis according to patient involvement: A scoping review. Int. J. Technol. Assess. Health Care, 39(1): e59.
66. Sahoo S., Sahoo J., Kumar S. et al. (2023) Distance is no longer a barrier to healthcare services: Current state and future trends of telehealth research. Int. Res., 33(3): 890–944.
67. Van Helmond A.T., Mortensen L.O., Plet‐Hansen K.S. et al. (2020) Electronic monitoring in fisheries: Lessons from global experiences and future opportunities. Fish and Fisheries, 21(1): 162–189. doi.org/10.1111/faf.12425.